International neural monitoring study group guideline 2018 part I: Staging bilateral thyroid surgery with monitoring loss of signal

  • Rick Schneider
    Martin Luther University Halle‐Wittenberg Department of General, Visceral, and Vascular Surgery Halle Germany
  • Gregory W. Randolph
    Division of Thyroid and Parathyroid Surgery, Department of Otolaryngology Massachusetts Eye and Ear Harvard Medical School Boston Massachusetts
  • Gianlorenzo Dionigi
    Division for Endocrine Surgery, at the Department of Human Pathology in Adulthood and Childhood “G. Barresi,” University Hospital G. Martino University of Messina Italy
  • Che‐Wei Wu
    Kaohsiung Medical University Hospital, Kaohsiung Medical University Otolaryngology–Head and Neck Surgery Kaohsiung Taiwan
  • Marcin Barczynski
    Jagiellonian University, Department of Endocrine Surgery, Third Chair of General Surgery Krakow Poland
  • Feng‐Yu Chiang
    Kaohsiung Medical University Hospital, Kaohsiung Medical University Otolaryngology–Head and Neck Surgery Kaohsiung Taiwan
  • Zaid Al‐Quaryshi
    University of Iowa Hospitals and Clinics, Otolaryngology Iowa City Iowa
  • Peter Angelos
    University of Chicago Division of Endocrine Surgery, Department of Surgery Chicago Illinois
  • Katrin Brauckhoff
    Haukeland Universitetssjukehus Department of Breast and Endocrine Surgery Bergen Norway
  • Claudio R. Cernea
    University of Sao Paulo Medical School Department of Head and Neck Surgery Sao Paulo SP Brazil
  • John Chaplin
    Gillies Hospital & Clinics Epsom New Zealand
  • Jonathan Cheetham
    Cornell University, Clinical Sciences, College of Veterinary Medicine Ithaca New York
  • Louise Davies
    VA Outcomes Group at the Veterans Affairs Medical Center Norwich Vermont
  • Peter E. Goretzki
    Stadtische Kliniken Neuss Lukaskrankenhaus GmbH Neuss Nordrhein‐Westfalen Germany
  • Dana Hartl
    Institut Gustave Roussy, Otolaryngology Head & Neck Surgery Villejuif France
  • Dipti Kamani
    Division of Thyroid and Parathyroid Surgery, Department of Otolaryngology Massachusetts Eye and Ear Harvard Medical School Boston Massachusetts
  • Emad Kandil
    Department of Surgery Tulane University School of Medicine New Orleans Louisiana
  • Natalia Kyriazidis
    State University of New York Upstate Medical University Otolaryngology Syracuse New York
  • Whitney Liddy
    Northwestern University Feinberg School of Medicine Department of Psychiatry and Behavioral Sciences, Otolaryngology Chicago Illinois
  • Lisa Orloff
    Stanford University School of Medicine, Otolaryngology, Division of Head and Neck Surgery Stanford California
  • Joseph Scharpf
    Cleveland Clinic, Otolaryngology Cleveland Ohio
  • Jonathan Serpell
    Alfred Hospital Melbourne Victoria Australia
  • Jennifer J. Shin
    Harvard Medical School, Otolaryngology Boston Massachusetts
  • Catherine F. Sinclair
    Icahn School of Medicine at Mount Sinai, Otolaryngology New York New York
  • Michael C. Singer
    Henry Ford Hospital, Otolaryngology–Head & Neck Surgery Detroit Michigan
  • Samuel K. Snyder
    University of Texas Rio Grande Valley School of Medicine Department of General Surgery Edinburg Texas
  • Neil S. Tolley
    St. Mary's Hospital, Imperial College Hospitals NHS Trust, St. Mary's Hospital London United Kingdom
  • Sam Van Slycke
    OLV Ziekenhuis Aalst Brussels Belgium
  • Erivelto Volpi
    Hospital das Clinicas–University of Sao Paulo Medical School Sao Paulo Brazil
  • Ian Witterick
    Mount Sinai Hospital Department of Otolaryngology Toronto Ontario Canada
  • Richard J. Wong
    Memorial Sloan‐Kettering Cancer Center, Department of Surgery, Head and Neck Service New York New York
  • Gayle Woodson
    865 Indianola Dr Merritt Island Florida
  • Mark Zafereo
    MD Anderson Cancer Center, Head and Neck Surgery Houston Texas U.S.A.
  • Henning Dralle
    Allgemeinchirurgie, Uniklinik Halle Halle/Saale Germany

Description

<jats:p>This publication offers modern, state‐of‐the‐art International Neural Monitoring Study Group (INMSG) guidelines based on a detailed review of the recent monitoring literature. The guidelines outline evidence‐based definitions of adverse electrophysiologic events, especially loss of signal, and their incorporation in surgical strategy. These recommendations are designed to reduce technique variations, enhance the quality of neural monitoring, and assist surgeons in the clinical decision‐making process involved in surgical management of recurrent laryngeal nerve. The guidelines are published in conjunction with the INMSG Guidelines Part II, Optimal Recurrent Laryngeal Nerve Management for Invasive Thyroid Cancer–Incorporation of Surgical, Laryngeal, and Neural Electrophysiologic Data.</jats:p><jats:p><jats:italic>Laryngoscope</jats:italic>, 128:S1–S17, 2018</jats:p>

Journal

Citations (2)*help

See more

Report a problem

Back to top